Quick navigation menu :

  1. Go to the content
  2. Go to main section's menu
  3. Go to Search tool
  4. Go to Help menu
  5. Go to modules
  6. Go to the list of keyboard shortcuts

This site uses cookies to store information on your computer. Some cookies on this site are essential and the site won’t work as expected without them. To learn more about cookies and their benefits, please view our cookies policy. You could also decide what kind of cookie the website could use or not use on our cookies settings page.
By closing this message or navigating within the website, you consent to our use of cookies on this device in accordance with our cookie policy unless you have disabled them.

Help menu :

  1. Sanofi Worldwide |
     
  2. Our UK Websites |
     
  3. Global Business Websites |
     
  4. Contact us |
  5. Site map |
  6. Help
  1. RSS
  2. Font size

    Reduce font size Increase font size  
 
 

Research & Development

Content :

Research & Development

January 21, 2013

Our Research & Development (R&D) strategy focuses on the innovations and technologies that enable us to respond to patients' unmet medical needs. We have a rich development portfolio of projects, which include innovative medicines, biotechnology products or vaccines.

 

Operating through acquisitions, partnerships and close scientific collaboration with academia and research institutions, Sanofi explores new research methodologies such as biotechnologies, nanotechnologies and biomarkers to identify projects that may lead to discovering potentially valuable new medicines in our priority disease areas: diabetes, oncology, opthalamology, infectious diseases, elderly patients and ageing, immuno-inflammation, fibrosis and tissue repair.

Our objective is to develop products tailored to the specific needs of patients in different parts of the world.  Taking a holistic approach to patient care, we work to extend our product range to treat all stages of a disease, from prevention to various stages of treatment.  This also supports pharmacological approaches by developing services and technologies to boost the efficacy of treatment and enhance patients' quality of life.

Of the 65 projects we currently have in our research and development, 17 are in Phase III or have been submitted for approval.

Module :

Corporate Information

Corporate Information

 

Sitewide_Sanofi_In_The_UK

Sanofi in the UK

Find out more about Sanofi UK's business units and locations, our investment in research and development, and our product pipeline

 

Sitewide_Sustainability

Sustainability

Sanofi is respected as a global leader in healthcare, partly because of the benefits of our medicines and vaccines, and also because of the ethical way we engage with patients, customers, colleagues, suppliers and healthcare authorities.